JLL, a leading professional services firm specialised in real estate, investment management, and development consultancy services, has highlighted that as governments in the Middle East push for increased localisation to attain self-sustainability in the healthcare sector, the heightened investor confidence is driving sustained demand across the healthcare value chain in the region. Recognising the promising landscape for the healthcare and life sciences sector in the MENA region, JLL recently advised a consortium led by UAE-based Fajr Capital to acquire a 65% stake in the ownership of the GCC business of Aster DM Healthcare. Having worked on 100+ healthcare projects in the region, JLL’s healthcare advisory team supported this prestigious transaction and ensured its successful outcome by providing comprehensive technical due diligence services to Fajr Capital.
Fajr Capital leads a consortium of investors whose investments will bolster the expansion plans of Aster DM Healthcare in key GCC markets such as the UAE and Saudi Arabia. The company’s long-term strategy will unlock value within the GCC’s dynamic healthcare landscape and enable greater access to quality services across physical and digital channels. , said, “The GCC’s healthcare expenditure is projected to reach .
Under their economic diversification agenda, countries in the GCC are driving the transformation of this critical sector with infrastructure development, clinical capabilities, human capital develop.
